+1 (704) 266-3234

Global Mesalamine Market Research Report 2020

Published on: Jan 2020 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 135


The global Mesalamine market is valued at xx million US$ in 2020 is expected to reach xx million US$ by the end of 2026, growing at a CAGR of xx% during 2021-2026.
This report focuses on Mesalamine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Mesalamine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Mesalamine market is segmented into
Capsule
Tablets

Segment by Application
Adult
Children

Global Mesalamine Market: Regional Analysis
The Mesalamine market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Mesalamine market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Mesalamine Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Mesalamine market include:
Allergan
Salix Pharmaceuticals
Nogra Pharma
AstraZeneca
Abbvie
Takeda
Janssen (Johnson & Johnson)
Pfizer
Ferring
Boehringer Ingelheim
Cosmo Pharmaceuticals
Teva
Mylan
Sandoz Mesalamine
Tillotts Pharma
Chiesi Farmaceutici
Dr Falk Pharma
Cipla
Synmosa Biopharma Corporation
Lunan Better Pharmaceutical
Shanghai Sine Promod Pharmaceutical

Table of Contents

1 Mesalamine Market Overview
1.1 Product Overview and Scope of Mesalamine
1.2 Mesalamine Segment by Type
1.2.1 Global Mesalamine Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Capsule
1.2.3 Tablets
1.3 Mesalamine Segment by Application
1.3.1 Mesalamine Sales Comparison by Application: 2020 VS 2026
1.3.2 Adult
1.3.3 Children
1.4 Global Mesalamine Market Size Estimates and Forecasts
1.4.1 Global Mesalamine Revenue 2015-2026
1.4.2 Global Mesalamine Sales 2015-2026
1.4.3 Mesalamine Market Size by Region: 2020 Versus 2026

2 Global Mesalamine Market Competition by Manufacturers
2.1 Global Mesalamine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Mesalamine Revenue Share by Manufacturers (2015-2020)
2.3 Global Mesalamine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Mesalamine Manufacturing Sites, Area Served, Product Type
2.5 Mesalamine Market Competitive Situation and Trends
2.5.1 Mesalamine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Mesalamine Players (Opinion Leaders)

3 Mesalamine Retrospective Market Scenario by Region
3.1 Global Mesalamine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Mesalamine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Mesalamine Market Facts & Figures by Country
3.3.1 North America Mesalamine Sales by Country
3.3.2 North America Mesalamine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Mesalamine Market Facts & Figures by Country
3.4.1 Europe Mesalamine Sales by Country
3.4.2 Europe Mesalamine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Mesalamine Market Facts & Figures by Region
3.5.1 Asia Pacific Mesalamine Sales by Region
3.5.2 Asia Pacific Mesalamine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Mesalamine Market Facts & Figures by Country
3.6.1 Latin America Mesalamine Sales by Country
3.6.2 Latin America Mesalamine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Mesalamine Market Facts & Figures by Country
3.7.1 Middle East and Africa Mesalamine Sales by Country
3.7.2 Middle East and Africa Mesalamine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Mesalamine Historic Market Analysis by Type
4.1 Global Mesalamine Sales Market Share by Type (2015-2020)
4.2 Global Mesalamine Revenue Market Share by Type (2015-2020)
4.3 Global Mesalamine Price Market Share by Type (2015-2020)
4.4 Global Mesalamine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Mesalamine Historic Market Analysis by Application
5.1 Global Mesalamine Sales Market Share by Application (2015-2020)
5.2 Global Mesalamine Revenue Market Share by Application (2015-2020)
5.3 Global Mesalamine Price by Application (2015-2020)

6 Company Profiles and Key Figures in Mesalamine Business
6.1 Allergan
6.1.1 Corporation Information
6.1.2 Allergan Description, Business Overview and Total Revenue
6.1.3 Allergan Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Allergan Products Offered
6.1.5 Allergan Recent Development
6.2 Salix Pharmaceuticals
6.2.1 Salix Pharmaceuticals Mesalamine Production Sites and Area Served
6.2.2 Salix Pharmaceuticals Description, Business Overview and Total Revenue
6.2.3 Salix Pharmaceuticals Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Salix Pharmaceuticals Products Offered
6.2.5 Salix Pharmaceuticals Recent Development
6.3 Nogra Pharma
6.3.1 Nogra Pharma Mesalamine Production Sites and Area Served
6.3.2 Nogra Pharma Description, Business Overview and Total Revenue
6.3.3 Nogra Pharma Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Nogra Pharma Products Offered
6.3.5 Nogra Pharma Recent Development
6.4 AstraZeneca
6.4.1 AstraZeneca Mesalamine Production Sites and Area Served
6.4.2 AstraZeneca Description, Business Overview and Total Revenue
6.4.3 AstraZeneca Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 AstraZeneca Products Offered
6.4.5 AstraZeneca Recent Development
6.5 Abbvie
6.5.1 Abbvie Mesalamine Production Sites and Area Served
6.5.2 Abbvie Description, Business Overview and Total Revenue
6.5.3 Abbvie Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Abbvie Products Offered
6.5.5 Abbvie Recent Development
6.6 Takeda
6.6.1 Takeda Mesalamine Production Sites and Area Served
6.6.2 Takeda Description, Business Overview and Total Revenue
6.6.3 Takeda Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Takeda Products Offered
6.6.5 Takeda Recent Development
6.7 Janssen (Johnson & Johnson)
6.6.1 Janssen (Johnson & Johnson) Mesalamine Production Sites and Area Served
6.6.2 Janssen (Johnson & Johnson) Description, Business Overview and Total Revenue
6.6.3 Janssen (Johnson & Johnson) Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Janssen (Johnson & Johnson) Products Offered
6.7.5 Janssen (Johnson & Johnson) Recent Development
6.8 Pfizer
6.8.1 Pfizer Mesalamine Production Sites and Area Served
6.8.2 Pfizer Description, Business Overview and Total Revenue
6.8.3 Pfizer Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Pfizer Products Offered
6.8.5 Pfizer Recent Development
6.9 Ferring
6.9.1 Ferring Mesalamine Production Sites and Area Served
6.9.2 Ferring Description, Business Overview and Total Revenue
6.9.3 Ferring Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Ferring Products Offered
6.9.5 Ferring Recent Development
6.10 Boehringer Ingelheim
6.10.1 Boehringer Ingelheim Mesalamine Production Sites and Area Served
6.10.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
6.10.3 Boehringer Ingelheim Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Boehringer Ingelheim Products Offered
6.10.5 Boehringer Ingelheim Recent Development
6.11 Cosmo Pharmaceuticals
6.11.1 Cosmo Pharmaceuticals Mesalamine Production Sites and Area Served
6.11.2 Cosmo Pharmaceuticals Mesalamine Description, Business Overview and Total Revenue
6.11.3 Cosmo Pharmaceuticals Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Cosmo Pharmaceuticals Products Offered
6.11.5 Cosmo Pharmaceuticals Recent Development
6.12 Teva
6.12.1 Teva Mesalamine Production Sites and Area Served
6.12.2 Teva Mesalamine Description, Business Overview and Total Revenue
6.12.3 Teva Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Teva Products Offered
6.12.5 Teva Recent Development
6.13 Mylan
6.13.1 Mylan Mesalamine Production Sites and Area Served
6.13.2 Mylan Mesalamine Description, Business Overview and Total Revenue
6.13.3 Mylan Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Mylan Products Offered
6.13.5 Mylan Recent Development
6.14 Sandoz Mesalamine
6.14.1 Sandoz Mesalamine Mesalamine Production Sites and Area Served
6.14.2 Sandoz Mesalamine Mesalamine Description, Business Overview and Total Revenue
6.14.3 Sandoz Mesalamine Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Sandoz Mesalamine Products Offered
6.14.5 Sandoz Mesalamine Recent Development
6.15 Tillotts Pharma
6.15.1 Tillotts Pharma Mesalamine Production Sites and Area Served
6.15.2 Tillotts Pharma Mesalamine Description, Business Overview and Total Revenue
6.15.3 Tillotts Pharma Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Tillotts Pharma Products Offered
6.15.5 Tillotts Pharma Recent Development
6.16 Chiesi Farmaceutici
6.16.1 Chiesi Farmaceutici Mesalamine Production Sites and Area Served
6.16.2 Chiesi Farmaceutici Mesalamine Description, Business Overview and Total Revenue
6.16.3 Chiesi Farmaceutici Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Chiesi Farmaceutici Products Offered
6.16.5 Chiesi Farmaceutici Recent Development
6.17 Dr Falk Pharma
6.17.1 Dr Falk Pharma Mesalamine Production Sites and Area Served
6.17.2 Dr Falk Pharma Mesalamine Description, Business Overview and Total Revenue
6.17.3 Dr Falk Pharma Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Dr Falk Pharma Products Offered
6.17.5 Dr Falk Pharma Recent Development
6.18 Cipla
6.18.1 Cipla Mesalamine Production Sites and Area Served
6.18.2 Cipla Mesalamine Description, Business Overview and Total Revenue
6.18.3 Cipla Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.18.4 Cipla Products Offered
6.18.5 Cipla Recent Development
6.19 Synmosa Biopharma Corporation
6.19.1 Synmosa Biopharma Corporation Mesalamine Production Sites and Area Served
6.19.2 Synmosa Biopharma Corporation Mesalamine Description, Business Overview and Total Revenue
6.19.3 Synmosa Biopharma Corporation Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.19.4 Synmosa Biopharma Corporation Products Offered
6.19.5 Synmosa Biopharma Corporation Recent Development
6.20 Lunan Better Pharmaceutical
6.20.1 Lunan Better Pharmaceutical Mesalamine Production Sites and Area Served
6.20.2 Lunan Better Pharmaceutical Mesalamine Description, Business Overview and Total Revenue
6.20.3 Lunan Better Pharmaceutical Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.20.4 Lunan Better Pharmaceutical Products Offered
6.20.5 Lunan Better Pharmaceutical Recent Development
6.21 Shanghai Sine Promod Pharmaceutical
6.21.1 Shanghai Sine Promod Pharmaceutical Mesalamine Production Sites and Area Served
6.21.2 Shanghai Sine Promod Pharmaceutical Mesalamine Description, Business Overview and Total Revenue
6.21.3 Shanghai Sine Promod Pharmaceutical Mesalamine Sales, Revenue and Gross Margin (2015-2020)
6.21.4 Shanghai Sine Promod Pharmaceutical Products Offered
6.21.5 Shanghai Sine Promod Pharmaceutical Recent Development

7 Mesalamine Manufacturing Cost Analysis
7.1 Mesalamine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Mesalamine
7.4 Mesalamine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Mesalamine Distributors List
8.3 Mesalamine Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Mesalamine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Mesalamine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Mesalamine by Type (2021-2026)
10.2 Mesalamine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Mesalamine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Mesalamine by Application (2021-2026)
10.3 Mesalamine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Mesalamine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Mesalamine by Region (2021-2026)
10.4 North America Mesalamine Estimates and Projections (2021-2026)
10.5 Europe Mesalamine Estimates and Projections (2021-2026)
10.6 Asia Pacific Mesalamine Estimates and Projections (2021-2026)
10.7 Latin America Mesalamine Estimates and Projections (2021-2026)
10.8 Middle East and Africa Mesalamine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables
Table 1. Global Mesalamine Sales (KG) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Mesalamine Sales (KG) Comparison by Application: 2020 VS 2026
Table 3. Global Mesalamine Market Size by Type (KG) (US$ Million) (2020 VS 2026)
Table 4. Global Key Mesalamine Manufacturers Covered in This Study
Table 5. Global Mesalamine Sales (KG) by Manufacturers (2015-2020)
Table 6. Global Mesalamine Sales Share by Manufacturers (2015-2020)
Table 7. Global Mesalamine Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Mesalamine Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Mesalamine Average Price (USD/KG) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Mesalamine Sales Sites and Area Served
Table 11. Manufacturers Mesalamine Product Types
Table 12. Global Mesalamine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Mesalamine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mesalamine as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Mesalamine Players
Table 16. Global Mesalamine Sales (KG) by Region (2015-2020)
Table 17. Global Mesalamine Sales Market Share by Region (2015-2020)
Table 18. Global Mesalamine Revenue (Million US$) by Region (2015-2020)
Table 19. Global Mesalamine Revenue Market Share by Region (2015-2020)
Table 20. North America Mesalamine Sales by Country (2015-2020) (KG)
Table 21. North America Mesalamine Sales Market Share by Country (2015-2020)
Table 22. North America Mesalamine Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Mesalamine Revenue Market Share by Country (2015-2020)
Table 24. Europe Mesalamine Sales by Country (2015-2020) (KG)
Table 25. Europe Mesalamine Sales Market Share by Country (2015-2020)
Table 26. Europe Mesalamine Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Mesalamine Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Mesalamine Sales by Region (2015-2020) (KG)
Table 29. Asia Pacific Mesalamine Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Mesalamine Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Mesalamine Revenue Market Share by Region (2015-2020)
Table 32. Latin America Mesalamine Sales by Country (2015-2020) (KG)
Table 33. Latin America Mesalamine Sales Market Share by Country (2015-2020)
Table 34. Latin America Mesalamine Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Mesalamine Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Mesalamine Sales by Country (2015-2020) (KG)
Table 37. Middle East and Africa Mesalamine Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Mesalamine Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Mesalamine Revenue Market Share by Country (2015-2020)
Table 40. Global Mesalamine Sales (KG) by Type (2015-2020)
Table 41. Global Mesalamine Sales Share by Type (2015-2020)
Table 42. Global Mesalamine Revenue (Million US$) by Type (2015-2020)
Table 43. Global Mesalamine Revenue Share by Type (2015-2020)
Table 44. Global Mesalamine Price (USD/KG) by Type (2015-2020)
Table 45. Global Mesalamine Sales (KG) by Application (2015-2020)
Table 46. Global Mesalamine Sales Market Share by Application (2015-2020)
Table 47. Global Mesalamine Sales Growth Rate by Application (2015-2020)
Table 48. Allergan Mesalamine Corporation Information
Table 49. Allergan Description and Business Overview
Table 50. Allergan Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)
Table 51. Allergan Main Product
Table 52. Allergan Recent Development
Table 53. Salix Pharmaceuticals Mesalamine Corporation Information
Table 54. Salix Pharmaceuticals Corporation Information
Table 55. Salix Pharmaceuticals Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)
Table 56. Salix Pharmaceuticals Main Product
Table 57. Salix Pharmaceuticals Recent Development
Table 58. Nogra Pharma Mesalamine Corporation Information
Table 59. Nogra Pharma Corporation Information
Table 60. Nogra Pharma Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)
Table 61. Nogra Pharma Main Product
Table 62. Nogra Pharma Recent Development
Table 63. AstraZeneca Mesalamine Corporation Information
Table 64. AstraZeneca Corporation Information
Table 65. AstraZeneca Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)
Table 66. AstraZeneca Main Product
Table 67. AstraZeneca Recent Development
Table 68. Abbvie Mesalamine Corporation Information
Table 69. Abbvie Corporation Information
Table 70. Abbvie Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)
Table 71. Abbvie Main Product
Table 72. Abbvie Recent Development
Table 73. Takeda Mesalamine Corporation Information
Table 74. Takeda Corporation Information
Table 75. Takeda Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)
Table 76. Takeda Main Product
Table 77. Takeda Recent Development
Table 78. Janssen (Johnson & Johnson) Mesalamine Corporation Information
Table 79. Janssen (Johnson & Johnson) Corporation Information
Table 80. Janssen (Johnson & Johnson) Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)
Table 81. Janssen (Johnson & Johnson) Main Product
Table 82. Janssen (Johnson & Johnson) Recent Development
Table 83. Pfizer Mesalamine Corporation Information
Table 84. Pfizer Corporation Information
Table 85. Pfizer Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)
Table 86. Pfizer Main Product
Table 87. Pfizer Recent Development
Table 88. Ferring Mesalamine Corporation Information
Table 89. Ferring Corporation Information
Table 90. Ferring Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)
Table 91. Ferring Main Product
Table 92. Ferring Recent Development
Table 93. Boehringer Ingelheim Mesalamine Corporation Information
Table 94. Boehringer Ingelheim Corporation Information
Table 95. Boehringer Ingelheim Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)
Table 96. Boehringer Ingelheim Main Product
Table 97. Boehringer Ingelheim Recent Development
Table 98. Cosmo Pharmaceuticals Mesalamine Corporation Information
Table 99. Cosmo Pharmaceuticals Corporation Information
Table 100. Cosmo Pharmaceuticals Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)
Table 101. Cosmo Pharmaceuticals Main Product
Table 102. Cosmo Pharmaceuticals Recent Development
Table 103. Teva Mesalamine Corporation Information
Table 104. Teva Corporation Information
Table 105. Teva Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)
Table 106. Teva Main Product
Table 107. Teva Recent Development
Table 108. Mylan Mesalamine Corporation Information
Table 109. Mylan Corporation Information
Table 110. Mylan Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)
Table 111. Mylan Main Product
Table 112. Mylan Recent Development
Table 113. Sandoz Mesalamine Mesalamine Corporation Information
Table 114. Sandoz Mesalamine Corporation Information
Table 115. Sandoz Mesalamine Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)
Table 116. Sandoz Mesalamine Main Product
Table 117. Sandoz Mesalamine Recent Development
Table 118. Tillotts Pharma Mesalamine Corporation Information
Table 119. Tillotts Pharma Corporation Information
Table 120. Tillotts Pharma Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)
Table 121. Tillotts Pharma Main Product
Table 122. Tillotts Pharma Recent Development
Table 123. Chiesi Farmaceutici Mesalamine Corporation Information
Table 124. Chiesi Farmaceutici Corporation Information
Table 125. Chiesi Farmaceutici Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)
Table 126. Chiesi Farmaceutici Main Product
Table 127. Chiesi Farmaceutici Recent Development
Table 128. Dr Falk Pharma Mesalamine Corporation Information
Table 129. Dr Falk Pharma Corporation Information
Table 130. Dr Falk Pharma Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)
Table 131. Dr Falk Pharma Main Product
Table 132. Dr Falk Pharma Recent Development
Table 133. Cipla Mesalamine Corporation Information
Table 134. Cipla Corporation Information
Table 135. Cipla Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)
Table 136. Cipla Main Product
Table 137. Cipla Recent Development
Table 138. Synmosa Biopharma Corporation Mesalamine Corporation Information
Table 139. Synmosa Biopharma Corporation Corporation Information
Table 140. Synmosa Biopharma Corporation Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)
Table 141. Synmosa Biopharma Corporation Main Product
Table 142. Synmosa Biopharma Corporation Recent Development
Table 143. Lunan Better Pharmaceutical Mesalamine Corporation Information
Table 144. Lunan Better Pharmaceutical Corporation Information
Table 145. Lunan Better Pharmaceutical Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)
Table 146. Lunan Better Pharmaceutical Main Product
Table 147. Lunan Better Pharmaceutical Recent Development
Table 148. Shanghai Sine Promod Pharmaceutical Mesalamine Corporation Information
Table 149. Shanghai Sine Promod Pharmaceutical Corporation Information
Table 150. Shanghai Sine Promod Pharmaceutical Mesalamine Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020)
Table 151. Shanghai Sine Promod Pharmaceutical Main Product
Table 152. Shanghai Sine Promod Pharmaceutical Recent Development
Table 153. Sales Base and Market Concentration Rate of Raw Material
Table 154. Key Suppliers of Raw Materials
Table 155. Mesalamine Distributors List
Table 156. Mesalamine Customers List
Table 157. Market Key Trends
Table 158. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 159. Key Challenges
Table 160. Global Mesalamine Sales (KG) Forecast by Type (2021-2026)
Table 161. Global Mesalamine Sales Market Share Forecast by Type (2021-2026)
Table 162. Global Mesalamine Revenue (Million US$) Forecast by Type (2021-2026)
Table 163. Global Mesalamine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 164. Global Mesalamine Sales (KG) Forecast by Application (2021-2026)
Table 165. Global Mesalamine Revenue (Million US$) Forecast by Application (2021-2026)
Table 166. Global Mesalamine Sales (KG) Forecast by Region (2021-2026)
Table 167. Global Mesalamine Sales Market Share Forecast by Region (2021-2026)
Table 168. Global Mesalamine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 169. Global Mesalamine Revenue Market Share Forecast by Region (2021-2026)
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Mesalamine
Figure 2. Global Mesalamine Sales Market Share by Type: 2020 VS 2026
Figure 3. Capsule Product Picture
Figure 4. Tablets Product Picture
Figure 5. Global Mesalamine Consumption Market Share by Application: 2020 VS 2026
Figure 6. Adult
Figure 7. Children
Figure 8. Global Mesalamine Market Size 2015-2026 (US$ Million)
Figure 9. Global Mesalamine Sales Capacity (KG) (2015-2026)
Figure 10. Global Mesalamine Market Size Market Share by Region: 2020 Versus 2026
Figure 11. Mesalamine Sales Share by Manufacturers in 2020
Figure 12. Global Mesalamine Revenue Share by Manufacturers in 2019
Figure 13. The Global 5 and 10 Largest Players: Market Share by Mesalamine Revenue in 2019
Figure 14. Mesalamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Mesalamine Sales Market Share by Region (2015-2020)
Figure 16. Global Mesalamine Sales Market Share by Region in 2019
Figure 17. Global Mesalamine Revenue Market Share by Region (2015-2020)
Figure 18. Global Mesalamine Revenue Market Share by Region in 2019
Figure 19. North America Mesalamine Sales Market Share by Country in 2019
Figure 20. North America Mesalamine Revenue Market Share by Country in 2019
Figure 21. U.S. Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 22. U.S. Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 23. Canada Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 24. Canada Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Europe Mesalamine Sales Market Share by Country in 2019
Figure 26. Europe Mesalamine Revenue Market Share by Country in 2019
Figure 27. Germany Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 28. Germany Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. France Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 30. France Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. U.K. Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 32. U.K. Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Italy Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 34. Italy Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Russia Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 36. Russia Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Asia Pacific Mesalamine Sales Market Share by Region in 2019
Figure 38. Asia Pacific Mesalamine Revenue Market Share by Region in 2019
Figure 39. China Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 40. China Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Japan Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 42. Japan Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. South Korea Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 44. South Korea Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. India Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 46. India Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Australia Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 48. Australia Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Taiwan Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 50. Taiwan Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Indonesia Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 52. Indonesia Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Thailand Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 54. Thailand Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Malaysia Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 56. Malaysia Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Philippines Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 58. Philippines Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Vietnam Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 60. Vietnam Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Latin America Mesalamine Sales Market Share by Country in 2019
Figure 62. Latin America Mesalamine Revenue Market Share by Country in 2019
Figure 63. Mexico Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 64. Mexico Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Brazil Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 66. Brazil Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Argentina Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 68. Argentina Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Middle East and Africa Mesalamine Sales Market Share by Country in 2019
Figure 70. Middle East and Africa Mesalamine Revenue Market Share by Country in 2019
Figure 71. Turkey Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 72. Turkey Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Saudi Arabia Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 74. Saudi Arabia Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. U.A.E Mesalamine Sales Growth Rate (2015-2020) (KG)
Figure 76. U.A.E Mesalamine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Sales Market Share of Mesalamine by Type (2015-2020)
Figure 78. Sales Market Share of Mesalamine by Type in 2019
Figure 79. Revenue Share of Mesalamine by Type (2015-2020)
Figure 80. Revenue Market Share of Mesalamine by Type in 2019
Figure 81. Global Mesalamine Sales Growth by Type (2015-2020) (KG)
Figure 82. Global Mesalamine Sales Market Share by Application (2015-2020)
Figure 83. Global Mesalamine Sales Market Share by Application in 2019
Figure 84. Global Revenue Share of Mesalamine by Application (2015-2020)
Figure 85. Global Revenue Share of Mesalamine by Application in 2020
Figure 86. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Salix Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Nogra Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Abbvie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Janssen (Johnson & Johnson) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Ferring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Cosmo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Sandoz Mesalamine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Tillotts Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Chiesi Farmaceutici Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Dr Falk Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Synmosa Biopharma Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Lunan Better Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 106. Shanghai Sine Promod Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Price Trend of Key Raw Materials
Figure 108. Manufacturing Cost Structure of Mesalamine
Figure 109. Manufacturing Process Analysis of Mesalamine
Figure 110. Mesalamine Industrial Chain Analysis
Figure 111. Channels of Distribution
Figure 112. Distributors Profiles
Figure 113. Porter's Five Forces Analysis
Figure 114. North America Mesalamine Sales (KG) and Growth Rate Forecast (2021-2026)
Figure 115. North America Mesalamine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Europe Mesalamine Sales (KG) and Growth Rate Forecast (2021-2026)
Figure 117. Europe Mesalamine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 118. Latin America Mesalamine Sales (KG) and Growth Rate Forecast (2021-2026)
Figure 119. Latin America Mesalamine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 120. Middle East and Africa Mesalamine Sales (KG) and Growth Rate Forecast (2021-2026)
Figure 121. Middle East and Africa Mesalamine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 122. Asia Pacific Mesalamine Sales (KG) and Growth Rate Forecast (2021-2026)
Figure 123. Asia Pacific Mesalamine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $4350
USD $5800
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.